NNVC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NanoViricides Inc

NYSE MKT | NNVC

1.23

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 5, 2025)

$21.96M

Market Cap

-

P/E Ratio

-0.5

EPS

$2.23

52 Week High

$0.94

52 Week Low

HEALTHCARE

Sector

NNVC Chart

Recent Chart
Price Action

NNVC Technicals

Tags:

NNVC Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$744K
Total Revenue $0
Cost Of Revenue $744K
Costof Goods And Services Sold $744K
Operating Income -$9.6M
Selling General And Administrative $4M
Research And Development $5.5M
Operating Expenses $9.6M
Investment Income Net -
Net Interest Income $125K
Interest Income $125K
Interest Expense $149M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $744K
Income Before Tax -$9.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.5M
Comprehensive Income Net Of Tax -
Ebit -$9.5M
Ebitda -$8.7M
Net Income -$9.5M

Revenue & Profitability

Earnings Performance

NNVC Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $8.8M
Total Current Assets $1.7M
Cash And Cash Equivalents At Carrying Value $1.6M
Cash And Short Term Investments $1.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $7.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $317K
Intangible Assets Excluding Goodwill $317K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $112K
Other Non Current Assets -
Total Liabilities $1.3M
Total Current Liabilities $1.3M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $26K
Other Non Current Liabilities -
Total Shareholder Equity $7.5M
Treasury Stock -
Retained Earnings -$149M
Common Stock $166
Common Stock Shares Outstanding $15M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$8.5M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $744K
Capital Expenditures $57K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$57K
Cashflow From Financing $5.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.5M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$744K
Total Revenue $0
Cost Of Revenue $744K
Costof Goods And Services Sold $744K
Operating Income -$9.6M
Selling General And Administrative $4M
Research And Development $5.5M
Operating Expenses $9.6M
Investment Income Net -
Net Interest Income $125K
Interest Income $125K
Interest Expense $149M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $744K
Income Before Tax -$9.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.5M
Comprehensive Income Net Of Tax -
Ebit -$9.5M
Ebitda -$8.7M
Net Income -$9.5M

NNVC News

NNVC Profile

NanoViricides Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

NanoViricides Inc. (NNVC) is an innovative nanobiopharmaceutical firm headquartered in Shelton, Connecticut, dedicated to the research and development of cutting-edge antiviral therapies. Leveraging its proprietary nanomedicine platform, the company creates targeted treatments that address various viral infections and significant unmet medical needs within the healthcare sector. With a robust clinical and preclinical pipeline, NanoViricides is well-positioned for substantial growth in the evolving landscape of antiviral solutions and continues to make strides in bringing its advanced therapies to market.

PAVS
+16.19%
$0.03
LPTX
+368.57%
$2.05
WBD
+6.27%
$26.08
IRBT
+21.78%
$3.69
NVDA
-0.52%
$182.41
INHD
+10.95%
$0.15
SOFI
-6.14%
$27.78
NFLX
-2.88%
$100.24
ASST
-7.79%
$0.90
TDIC
+40.20%
$0.39
BYND
-1.61%
$1.22
INTC
+2.24%
$41.41
PLUG
-1.34%
$2.20
WHLR
+97.83%
$6.41
IPG
-1.95%
$24.57
ONDS
-1.30%
$9.07
VALE
-4.86%
$12.90
VHAI
0.00%
$0.00
AXDX
-61.36%
$0.03
BBD
-8.81%
$3.31
ABEV
-4.65%
$2.46
ITUB
-6.44%
$7.55
AAL
+3.27%
$14.81
TSLA
+0.10%
$455.00
DBRG
+45.26%
$14.12
F
-0.83%
$13.03
RGTI
-6.48%
$28.11
ADAP
-15.14%
$0.05
DNN
-3.52%
$2.74
YGMZ
+24.25%
$0.07
BITF
-5.80%
$2.92
AAPL
-0.68%
$278.78
HPE
+1.87%
$23.33
BMNR
-6.19%
$34.06
RR
-2.83%
$4.46
PFE
+1.28%
$26.03
SOND
-23.45%
$0.12
GRAB
-2.07%
$5.19
PBR
-5.82%
$12.13
ACHR
-3.91%
$8.60
NFE
+12.14%
$1.57
KEY
+0.78%
$19.26
RIVN
-0.60%
$17.95
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
JFBR
-36.00%
$1.60
ADD
-25.47%
$0.05
QBTS
-6.02%
$27.00
BMNU
-11.80%
$8.22
MARA
-5.62%
$11.74
NIO
+0.59%
$5.04
SRM
+53.27%
$10.30
BAC
+0.12%
$53.95
SNAP
+1.93%
$7.91
AMD
+0.92%
$217.97
AMZN
+0.18%
$229.53
KITT
-4.27%
$1.12
CLSK
-8.74%
$13.71
DVLT
-8.60%
$1.70
PLTR
+2.15%
$181.76
CHR
+1.50%
$0.04
AKAN
-0.87%
$0.93
GGB
-5.94%
$3.48
BTG
0.00%
$4.56
WLGS
-5.57%
$0.04
SATS
+10.06%
$82.00
QCLS
-1.01%
$6.85
TNFA
-1.01%
$6.85
MTSR
-0.35%
$70.50
T
-0.43%
$25.28
GOOGL
+1.14%
$321.27
IREN
-3.74%
$44.71
APLD
+0.25%
$31.22
PSKY
-9.81%
$13.36
PLTD
-2.10%
$6.52
SMR
-6.38%
$21.39
VZ
+1.04%
$41.69
HBAN
-1.16%
$16.90
CIFR
-2.77%
$19.28
AVGO
+2.41%
$390.24
AIIO
-6.92%
$0.60
NWTN
-6.92%
$0.60
CGC
-4.95%
$1.15
BTBT
-6.72%
$2.22
WMT
+0.23%
$115.11
ORCL
+1.51%
$217.58
AFMD
-34.94%
$0.18
AGNC
+1.23%
$10.62
HOOD
-3.74%
$131.95
IXHL
-4.63%
$0.45
KOS
+7.47%
$1.15
BURU
-4.73%
$0.23
MSFT
+0.48%
$483.16
IONZ
+7.09%
$3.32
HIMS
-2.04%
$39.20
PMCB
+0.82%
$1.22
TGL
+276.44%
$25.44
GPUS
-4.52%
$0.27
TWNP
-13.64%
$0.98
MRVL
+0.73%
$98.91
PAVS
+16.19%
$0.03
LPTX
+368.57%
$2.05
WBD
+6.27%
$26.08
IRBT
+21.78%
$3.69
NVDA
-0.52%
$182.41
INHD
+10.95%
$0.15
SOFI
-6.14%
$27.78
NFLX
-2.88%
$100.24
ASST
-7.79%
$0.90
TDIC
+40.20%
$0.39
BYND
-1.61%
$1.22
INTC
+2.24%
$41.41
PLUG
-1.34%
$2.20
WHLR
+97.83%
$6.41
IPG
-1.95%
$24.57
ONDS
-1.30%
$9.07
VALE
-4.86%
$12.90
VHAI
0.00%
$0.00
AXDX
-61.36%
$0.03
BBD
-8.81%
$3.31
ABEV
-4.65%
$2.46
ITUB
-6.44%
$7.55
AAL
+3.27%
$14.81
TSLA
+0.10%
$455.00
DBRG
+45.26%
$14.12
F
-0.83%
$13.03
RGTI
-6.48%
$28.11
ADAP
-15.14%
$0.05
DNN
-3.52%
$2.74
YGMZ
+24.25%
$0.07
BITF
-5.80%
$2.92
AAPL
-0.68%
$278.78
HPE
+1.87%
$23.33
BMNR
-6.19%
$34.06
RR
-2.83%
$4.46
PFE
+1.28%
$26.03
SOND
-23.45%
$0.12
GRAB
-2.07%
$5.19
PBR
-5.82%
$12.13
ACHR
-3.91%
$8.60
NFE
+12.14%
$1.57
KEY
+0.78%
$19.26
RIVN
-0.60%
$17.95
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
JFBR
-36.00%
$1.60
ADD
-25.47%
$0.05
QBTS
-6.02%
$27.00
BMNU
-11.80%
$8.22
MARA
-5.62%
$11.74
NIO
+0.59%
$5.04
SRM
+53.27%
$10.30
BAC
+0.12%
$53.95
SNAP
+1.93%
$7.91
AMD
+0.92%
$217.97
AMZN
+0.18%
$229.53
KITT
-4.27%
$1.12
CLSK
-8.74%
$13.71
DVLT
-8.60%
$1.70
PLTR
+2.15%
$181.76
CHR
+1.50%
$0.04
AKAN
-0.87%
$0.93
GGB
-5.94%
$3.48
BTG
0.00%
$4.56
WLGS
-5.57%
$0.04
SATS
+10.06%
$82.00
QCLS
-1.01%
$6.85
TNFA
-1.01%
$6.85
MTSR
-0.35%
$70.50
T
-0.43%
$25.28
GOOGL
+1.14%
$321.27
IREN
-3.74%
$44.71
APLD
+0.25%
$31.22
PSKY
-9.81%
$13.36
PLTD
-2.10%
$6.52
SMR
-6.38%
$21.39
VZ
+1.04%
$41.69
HBAN
-1.16%
$16.90
CIFR
-2.77%
$19.28
AVGO
+2.41%
$390.24
AIIO
-6.92%
$0.60
NWTN
-6.92%
$0.60
CGC
-4.95%
$1.15
BTBT
-6.72%
$2.22
WMT
+0.23%
$115.11
ORCL
+1.51%
$217.58
AFMD
-34.94%
$0.18
AGNC
+1.23%
$10.62
HOOD
-3.74%
$131.95
IXHL
-4.63%
$0.45
KOS
+7.47%
$1.15
BURU
-4.73%
$0.23
MSFT
+0.48%
$483.16
IONZ
+7.09%
$3.32
HIMS
-2.04%
$39.20
PMCB
+0.82%
$1.22
TGL
+276.44%
$25.44
GPUS
-4.52%
$0.27
TWNP
-13.64%
$0.98
MRVL
+0.73%
$98.91
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.